This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Astellas Pharma Gmbh. Active years: 2011-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2019
Title: Kazuhiko Osoda: Innovator in Pharmaceutical Chemistry
Introduction
Kazuhiko Osoda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the human body. With a total of 2 patents, his work has the potential to impact the treatment of various medical conditions.
Latest Patents
Osoda's latest patents include a piperazine derivative designed to act as an MCreceptor agonist. This compound has been shown to have an action related to MCreceptor agonists, making it a promising candidate for preventing or treating bladder and urinary tract diseases. These conditions include underactive bladder, hypotonic bladder, acontractile bladder, detrusor underactivity, neurogenic bladder, urethral relaxation failure, detrusor-external urethral sphincter dyssynergia, and voiding dysfunctions associated with benign prostatic hyperplasia.
Another significant patent involves a propane-1,3-dione derivative or its salt, which serves as a GnRH receptor antagonist. This compound has demonstrated a potent GnRH receptor antagonistic effect, making it useful for treating sex hormone-dependent diseases, particularly those related to GnRH. The compound also exhibits excellent metabolic stability in humans and minimal drug interactions, enhancing its potential as a pharmaceutical agent.
Career Highlights
Kazuhiko Osoda is currently associated with Astellas Pharma GmbH, where he continues to innovate in the field of drug development. His work focuses on creating effective treatments for complex medical conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Osoda has collaborated with notable colleagues, including Masaaki Hirano and Isao Kinoyama. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Kazuhiko Osoda's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work not only addresses critical medical needs but also paves the way for future advancements in treatment options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
